{"id":"https://openalex.org/W2948060932","doi":"https://doi.org/10.1182/blood.v130.suppl_1.5271.5271","title":"Examining the Frequency of Phlebotomy in Patients with Polycythemia Vera (PV) in the United States: An Analysis of Data from the REVEAL Study","display_name":"Examining the Frequency of Phlebotomy in Patients with Polycythemia Vera (PV) in the United States: An Analysis of Data from the REVEAL Study","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W2948060932","doi":"https://doi.org/10.1182/blood.v130.suppl_1.5271.5271","mag":"2948060932"},"language":"en","primary_location":{"id":"mag:2948060932","doi":"https://doi.org/10.1182/blood.v130.suppl_1.5271.5271","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/5271/81044/Examining-the-Frequency-of-Phlebotomy-in-Patients","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112233517","display_name":"Ralph Vincent Boccia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129209","display_name":"Center for Cancers and Blood Disorders","ror":"https://ror.org/03jh7ct92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210129209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph V. Boccia","raw_affiliation_strings":["Center for Cancer and Blood Disorders, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer and Blood Disorders, Bethesda, MD","institution_ids":["https://openalex.org/I4210129209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064274137","display_name":"Pedro Manuel Sanz-Altamira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pedro Sanz-Altamira","raw_affiliation_strings":["Dana\u2010Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana\u2010Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110294727","display_name":"Khuda Dad Khan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098196","display_name":"KentuckyOne Health","ror":"https://ror.org/00f1vw968","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098196"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khuda Dad Khan","raw_affiliation_strings":["Kentucky One Health, Louisville, KY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kentucky One Health, Louisville, KY","institution_ids":["https://openalex.org/I4210098196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112627345","display_name":"Dmitriy P. Berenzon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282516798","display_name":"Atrium Health Wake Forest Baptist","ror":"https://ror.org/04v8djg66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I4387930303","display_name":"Wake Forest Baptist Comprehensive Cancer Center","ror":"https://ror.org/0512csj88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I4387930303","https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dmitriy Berenzon","raw_affiliation_strings":["Comprehensive Cancer Center, Wake Forest Baptist Health, Comprehensive Cancer Center, Wake Forest Baptist Health, Winston Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, Wake Forest Baptist Health, Comprehensive Cancer Center, Wake Forest Baptist Health, Winston Salem, NC","institution_ids":["https://openalex.org/I1282516798","https://openalex.org/I4387930303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056812072","display_name":"Ellen Friedman","orcid":"https://orcid.org/0009-0009-1344-3525","observed_orcids":["https://orcid.org/0009-0009-1344-3525"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellen Friedman","raw_affiliation_strings":["The Univ. Hospital For the Albert Einstein College of Medicine, Bronx, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Univ. Hospital For the Albert Einstein College of Medicine, Bronx, NY","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103747728","display_name":"Ahmad Bilal Naim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I924451375","display_name":"Incyte (United States)","ror":"https://ror.org/00cvzzg84","country_code":"US","type":"company","lineage":["https://openalex.org/I924451375"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad Naim","raw_affiliation_strings":["Incyte Corp, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incyte Corp, Wilmington, DE","institution_ids":["https://openalex.org/I924451375"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091492816","display_name":"Dilan Chamikara Paranagama","orcid":"https://orcid.org/0000-0001-6162-1992","observed_orcids":["https://orcid.org/0000-0001-6162-1992"]},"institutions":[{"id":"https://openalex.org/I924451375","display_name":"Incyte (United States)","ror":"https://ror.org/00cvzzg84","country_code":"US","type":"company","lineage":["https://openalex.org/I924451375"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dilan Paranagama","raw_affiliation_strings":["Incyte Corp, Wilmington, DE"],"raw_orcid":"https://orcid.org/0000-0001-6162-1992","affiliations":[{"raw_affiliation_string":"Incyte Corp, Wilmington, DE","institution_ids":["https://openalex.org/I924451375"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["UT Health San Antonio Cancer Center - An NCI Designated Cancer Center, San Antonio, TX"],"raw_orcid":"https://orcid.org/0000-0001-5880-7972","affiliations":[{"raw_affiliation_string":"UT Health San Antonio Cancer Center - An NCI Designated Cancer Center, San Antonio, TX","institution_ids":["https://openalex.org/I4390039360"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1541,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.54063507,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"130","issue":null,"first_page":"5271","last_page":"5271"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.8980000019073486},{"id":"https://openalex.org/keywords/phlebotomy","display_name":"phlebotomy","score":0.949999988079071},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.9240000247955322},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.6600000262260437},{"id":"https://openalex.org/keywords/work-productivity-loss","display_name":"work productivity loss","score":0.6119999885559082},{"id":"https://openalex.org/keywords/iron-deficiency","display_name":"iron deficiency","score":0.6430000066757202},{"id":"https://openalex.org/keywords/symptom-burden","display_name":"symptom burden","score":0.6079999804496765},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.35499998927116394},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.5529999732971191},{"id":"https://openalex.org/keywords/newly-diagnosed-patients","display_name":"newly diagnosed patients","score":0.6069999933242798},{"id":"https://openalex.org/keywords/individualized-treatment-decision-making","display_name":"individualized treatment decision-making","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C2777357209","wikidata":"https://www.wikidata.org/wiki/Q3595842","display_name":"Phlebotomy","level":2,"score":0.9928330779075623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8324776887893677},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6158283948898315},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.508410632610321},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.43983709812164307},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40455132722854614},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.32398343086242676}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2948060932","doi":"https://doi.org/10.1182/blood.v130.suppl_1.5271.5271","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/5271/81044/Examining-the-Frequency-of-Phlebotomy-in-Patients","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2467899521","https://openalex.org/W2590048991","https://openalex.org/W4405053609","https://openalex.org/W7204725668","https://openalex.org/W7204729914","https://openalex.org/W7162584603","https://openalex.org/W7163579815","https://openalex.org/W2889887613","https://openalex.org/W7204720535","https://openalex.org/W2531766651"],"abstract_inverted_index":{"Abstract":[0],"Background:Phlebotomy":[3],"is":[4,67,97],"integral":[5],"to":[6,154,179,224,250,257],"the":[7,39,53,100,120,135,145,212,270],"clinical":[8],"management":[9],"of":[10,43,56,72,95,203,211,215,217,229,241,273],"patients":[11,73,96,166,190,219],"with":[12,77,195,207,266],"PV;":[13],"however,":[14],"it":[15],"may":[16,26,276],"be":[17],"inconvenient":[18],"and/or":[19],"poorly":[20],"tolerated.":[21],"Frequent":[22],"and":[23,33,60,84,115,133,140,171,245,254,275,299],"long-term":[24],"phlebotomies":[25,57,204,226,232,244],"cause":[27],"iron":[28],"deficiency,":[29],"increased":[30],"symptom":[31],"burden,":[32],"lost":[34],"productivity.":[35],"This":[36],"analysis":[37],"from":[38,149],"Prospective":[40],"Observational":[41],"Study":[42],"Patients":[44,194,235,248],"With":[45],"PV":[46,78,198],"in":[47,221],"US":[48],"Clinical":[49],"Practices":[50],"(REVEAL)":[51],"describes":[52],"patient-reported":[54,85,271],"burden":[55,94,103,272],"at":[58,152,227],"enrollment":[59,132],"\u22646":[61],"months":[62,130],"post-enrollment.":[63],"Design:":[65],"REVEAL":[66,222],"a":[68,200,208,238],"prospective,":[69],"observational":[70],"study":[71],"aged":[74],"\u226518":[75],"years":[76,183],"under":[79],"physician":[80],"supervision.":[81],"Physician":[82],"assessments":[83],"outcomes":[86],"are":[87,147],"being":[88],"collected":[89],"every":[90,107],"3":[91,108,129],"months.":[92],"Phlebotomy-related":[93,138],"evaluated":[98],"using":[99],"21-item":[101],"phlebotomy":[102,127,274],"questionnaire":[104],"(PBQ-21)":[105],"administered":[106],"months,":[109],"assessing":[110],"frequency,":[111],"time":[112,242],"needed,":[113],"inconvenience,":[114],"phlebotomy-related":[116],"adverse":[117],"effects.":[118],"Of":[119],"2510":[121],"enrolled":[122,220],"patients,":[123],"1173":[124],"had":[125],"\u22651":[126],"within":[128],"before":[131],"completed":[134],"PBQ-21":[136],"questionnaire.":[137],"effects":[139],"bother/inconvenience":[141],"(\u226424":[142],"hours":[143],"following":[144],"procedure)":[146],"graded":[148],"1":[150],"(not":[151],"all)":[153],"4":[155],"(extremely).":[156],"Findings:":[158],"Median":[159,174],"(range)":[160],"age":[161],"was":[162,181],"65":[163],"(22-95)":[164],"years;":[165],"were":[167],"mostly":[168],"male":[169],"(61.0%)":[170],"white":[172],"(91.2%).":[173],"disease":[175],"duration":[176,216],"(PV":[177],"diagnosis":[178],"enrollment)":[180],"3.2":[182],"(range,":[184],"0-39.2).":[185],"At":[186],"enrollment,":[187],"newly":[188,196],"diagnosed":[189,197],"(":[191],"Conclusion:":[193],"experience":[199],"greater":[201],"number":[202],"than":[205],"those":[206],"longer":[209],"history":[210],"disease.":[213],"Irrespective":[214],"disease,":[218],"continued":[223],"receive":[225],"rate":[228],"approximately":[230],"8":[231],"per":[233],"year.":[234],"reported":[236],"spending":[237],"considerable":[239],"amount":[240],"undergoing":[243],"missing":[246],"work.":[247],"continue":[249],"report":[251],"distress,":[252],"bother,":[253],"inconvenience":[255],"due":[256],"phlebotomies.":[258],"Implications:":[260],"These":[261],"findings":[262],"provide":[263],"healthcare":[264],"professionals":[265],"important":[267],"insight":[268],"into":[269],"help":[277],"guide":[278],"individualized":[279],"treatment":[280],"decisions.":[281],"Disclosures":[285],"Boccia:":[287],"Amgen:":[288],"Honoraria,":[289,293,305,309,313,317],"Speakers":[290,294,306,310,314,318],"Bureau;":[291,295,307,311,315],"Celgene:":[292],"Center":[296],"for":[297],"Cancer":[298],"Blood":[300],"Disorders:":[301],"Research":[302,323,328,333,338,358,369,374,378,382],"Funding;":[303,359,370,375,379],"Abbvie:":[304],"DSI:":[308],"Takeda:":[312],"Genentech:":[316],"Bureau.":[319],"Sanz-Altamira:":[320],"Incyte":[321,326,331,336,341,347,380],"Corporation:":[322,327,332,337,342,348,355,377,381],"Funding.":[324,329,334,339,383],"Khan:":[325],"Berenzon:":[330],"Friedman:":[335],"Naim:":[340],"Employment,":[343,349],"Equity":[344,350],"Ownership.":[345,351],"Paranagama:":[346],"Mesa:":[352],"Novartis":[353],"Pharmaceuticals":[354],"Consultancy;":[356,361,365],"Promedico:":[357],"Ariad:":[360],"Galena":[362],"Biopharma,":[363],"Inc.:":[364,368],"Gilead":[366],"Sciences,":[367],"CTI":[371],"BioPharma":[372],"Corp.:":[373],"Celgene":[376]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-06-14T00:00:00"}